With external magnet application, IFN-γ-adsorbed MNPs could be delivered more specifically to the tumor site, limiting the off-target-induced cytotoxicity in healthy tissues boosting stronger immunogenicity of cancer cells, and inhibiting cancer angiogenesis [51]. The gene discussed is IFNG; the disease is cancer.